These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37727753)

  • 1. Pharmacotherapy in patients with vasomotor disorders.
    Boerhout CKM; Feenstra RGT; van de Hoef TP; Piek JJ; Beijk MAM
    Int J Cardiol Heart Vasc; 2023 Oct; 48():101267. PubMed ID: 37727753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.
    Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Konst RE; Damman P; Pellegrini D; Hartzema-Meijer MJ; van Uden BJC; Jansen TPJ; Brandsma J; Vart P; Gehlmann H; Maas AHEM; van Royen N; Elias-Smale SE
    Int J Cardiol; 2021 Jun; 333():14-20. PubMed ID: 33711394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angina and Non-Obstructive Coronary Artery (ANOCA) Patients with Coronary Vasomotor Disorders.
    La S; Tavella R; Wu J; Pasupathy S; Zeitz C; Worthley M; Sinhal A; Arstall M; Spertus JA; Beltrame JF
    Life (Basel); 2023 Nov; 13(11):. PubMed ID: 38004330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review.
    Marchini F; Pompei G; D'Aniello E; Marrone A; Caglioni S; Biscaglia S; Campo G; Tebaldi M
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):151-161. PubMed ID: 35678926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Approach for Angina and Non-Obstructive Coronary Arteries: A State-of-the-Art Review.
    Boerhout CKM; Beijk MAM; Damman P; Piek JJ; van de Hoef TP
    Korean Circ J; 2023 Aug; 53(8):519-534. PubMed ID: 37525496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient Management of Patients With Angina With No Obstructive Coronary Arteries: How to Come to a Proper Diagnosis and Therapy.
    Meeder JG; Hartzema-Meijer MJ; Jansen TPJ; Konst RE; Damman P; Elias-Smale SE
    Front Cardiovasc Med; 2021; 8():716319. PubMed ID: 34796207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
    Crooijmans C; Jansen TPJ; Konst RE; Woudstra J; Appelman Y; den Ruijter HM; Onland-Moret NC; Meeder JG; de Vos AMJ; Paradies V; Woudstra P; Sjauw KD; van 't Hof A; Meuwissen M; Winkler P; Boersma E; van de Hoef TP; Maas AHEM; Dimitriu-Leen AC; van Royen N; Elias-Smale SE; Damman P;
    Int J Cardiol; 2023 May; 379():1-8. PubMed ID: 36863419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery spasm and impaired myocardial perfusion in patients with ANOCA: Predictors from a multimodality study using stress CMR and acetylcholine testing.
    Pirozzolo G; Martínez Pereyra V; Hubert A; Guenther F; Sechtem U; Bekeredjian R; Mahrholdt H; Ong P; Seitz A
    Int J Cardiol; 2021 Nov; 343():5-11. PubMed ID: 34499976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries.
    Montone RA; Niccoli G; Russo M; Giaccari M; Del Buono MG; Meucci MC; Gurgoglione F; Vergallo R; D'Amario D; Buffon A; Leone AM; Burzotta F; Aurigemma C; Trani C; Liuzzo G; Lanza GA; Crea F
    Clin Res Cardiol; 2020 Apr; 109(4):435-443. PubMed ID: 31270616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries?
    Jansen TPJ; van Keeken K; Konst RE; Dimitriu-Leen A; Maas AHEM; van Royen N; Damman P; Elias-Smale S
    Front Cardiovasc Med; 2021; 8():804731. PubMed ID: 35097023
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries.
    Feenstra RGT; Boerhout CKM; Woudstra J; Vink CEM; Wittekoek ME; de Waard GA; Appelman Y; Eringa EC; Marques KMJ; de Winter RJ; Beijk MAM; van de Hoef TP; Piek JJ
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012017. PubMed ID: 35904014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of Ischemic Heart Disease.
    Kaski JC; Crea F; Gersh BJ; Camici PG
    Circulation; 2018 Oct; 138(14):1463-1480. PubMed ID: 30354347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing-a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA).
    McChord J; Pereyra VM; Froebel S; Bekeredjian R; Schwab M; Ong P
    Front Cardiovasc Med; 2023; 10():1156456. PubMed ID: 37396593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA).
    Maayah M; Latif N; Vijay A; Gallegos CM; Cigarroa N; Posada Martinez EL; Mazure CM; Miller EJ; Spatz ES; Shah SM
    J Soc Cardiovasc Angiogr Interv; 2024 Aug; 3(8):102195. PubMed ID: 39166160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index.
    Feenstra RGT; Seitz A; Boerhout CKM; de Winter RJ; Ong P; Beijk MAM; Piek JJ; Sechtem U; van de Hoef TP
    Int J Cardiol; 2023 Jan; 371():16-20. PubMed ID: 36174827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
    Parikh RV; Pargaonkar V; Ball RL; Kobayashi Y; Kimura T; Yeung AC; Cooke JP; Tremmel JA
    Int J Cardiol; 2020 Jan; 299():7-11. PubMed ID: 31416658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles and pitfalls in coronary vasomotor function testing.
    Feenstra RGT; Seitz A; Boerhout CKM; Bukkems LH; Stegehuis VE; Teeuwisse PJI; de Winter RJ; Sechtem U; Piek JJ; van de Hoef TP; Ong P; Beijk MAM
    EuroIntervention; 2022 Feb; 17(15):1271-1280. PubMed ID: 34278990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease.
    Jansen TPJ; Elias-Smale SE; van den Oord S; Gehlmann H; Dimitiriu-Leen A; Maas AHEM; Konst RE; van Royen N; Damman P
    Front Cardiovasc Med; 2021; 8():750071. PubMed ID: 34722680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.